USPTO serial 79222937
E-PHARMA ALWAYS TO CREATE SOLUTIONS
Reviewed by CopyMark Law Group
Reg. 5624713Status 709
- Filing date
- Status date
- Registration date
- Dec 11, 2018
- Examiner
- RICHARDS, LESLIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with E-PHARMA ALWAYS TO CREATE SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Perla M. Kuhn
Perla M. Kuhn Fox Rothschild LLP997 Lenox Drive, Building 3,Princeton Pike Corporate CenterLawrenceville, NJ 08648-2311Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of effervescent tablets and/or granulated effervescent preparations manufactured on behalf on third parties; pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of orally disintegrating tablets and orally disintegrating granules and soluble granules manufactured on behalf of third parties; pharmaceutical preparations for the treatment of anemia, cold and flu, gastro-intestinal diseases, osteroporosis, respiratory diseases, for use in urology, gynecological disease, central nervous system and for pain relief and food supplement in the form of granules for suspension and chewable tablets manufactured on behalf of third parties | SECTION 71 - CANCELLED | — |
| 040 | Processing of chemical and/or pharmaceutical substances into effervescent tablets, granulated effervescent preparations, orally disintegrating tablets, orally disintegrating granules, soluble granules, granules for suspension, chewable tablets | SECTION 71 - CANCELLED | — |
| 042 | Research and development of pharmaceutical preparations and food integrators in the form of effervescent tablets, granulated effervescent preparations, orally disintegrating tablets, orally disintegrating granules, soluble granules, granules for suspension, chewable tablets; scientific and industrial research in the field of chemistry and pharmacology; scientific analytical laboratory services; chemical research and analysis | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by E-PHARMA TRENTO S.p.A.
- Other trademarks owned by E-PHARMA TRENTO S.p.A.
- Other trademarks owned by E-PHARMA TRENTO S.p.A.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named E-PHARMA ALWAYS TO CREATE SOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 27, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 27, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 11, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 5, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 19, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 19, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 11, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 11, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 25, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 25, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 21, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 5, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 5, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 5, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 20, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 3, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 3, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 3, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 22, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 21, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 14, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |